Passos Leny, Talhari Carolina, Santos Monica, Ribeiro-Rodrigues Rodrigo, Ferreira Luiz Carlos de Lima, Talhari Sinesio
Fundação de Hematologia e Hemoterapia do Amazonas, Manaus, AM, Brasil.
An Bras Dermatol. 2011 Jul-Aug;86(4 Suppl 1):S168-72. doi: 10.1590/s0365-05962011000700044.
A 27-year-old HIV-positive male patient with disseminated cutaneous histoplasmosis was treated with both HAART and amphotericin B (total accumulated dose of 0.5 g). Amphotericin B was later replaced with itraconazole (200mg/day). Two months after therapy had been started and the cutaneous lesions had healed, the patient interrupted both treatments voluntarily and his health deteriorated. HAART was then re-introduced and CD4+ cell count increased sharply at the same time as lymph node histoplasmosis was diagnosed. This paradoxical response? the relapse of histoplasmosis and concomitant increase in CD4+ cell count and undetectable viral load after resumption of HAART ? suggests that this was a case of immune reconstitution inflammatory syndrome (IRIS).
一名27岁的播散性皮肤组织胞浆菌病HIV阳性男性患者接受了高效抗逆转录病毒治疗(HAART)和两性霉素B(总累积剂量0.5g)治疗。两性霉素B后来被伊曲康唑(200mg/天)替代。治疗开始两个月后皮肤病变愈合,患者自行中断了两种治疗,随后健康状况恶化。然后重新开始HAART治疗,同时诊断出淋巴结组织胞浆菌病时CD4+细胞计数急剧增加。这种矛盾的反应——组织胞浆菌病复发以及重新开始HAART治疗后CD4+细胞计数增加且病毒载量检测不到——提示这是一例免疫重建炎症综合征(IRIS)。